Time limited eating in adolescents with obesity (time LEAd): Study protocol
| Autor: | Choo Phei Wee, Elizabeth Hegedus, Monica Naguib, Cassandra Fink, Kelleen Lopez, Michael I. Goran, Jennifer K. Raymond, Janelle Gonzalez, Alaina P. Vidmar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
Blood Glucose medicine.medical_specialty Pediatric Obesity Adolescent Type 2 diabetes Article law.invention Randomized controlled trial Weight loss law Intervention (counseling) Weight management medicine Humans Pharmacology (medical) Prospective Studies Child Glycemic Randomized Controlled Trials as Topic business.industry Blood Glucose Self-Monitoring General Medicine medicine.disease Obesity Clinical trial Diabetes Mellitus Type 2 Physical therapy medicine.symptom business |
| Zdroj: | Contemp Clin Trials |
| Popis: | BACKGROUND: Time limited eating (TLE) has been shown to be effective for weight loss and improvement of glycemic control in adults with obesity and type 2 diabetes (T2D), but has not been well studied in adolescents. TLE may be a more feasible, flexible and effective dietary intervention for adolescents because it removes the need for intensive counting of calories or macronutrients, and emphasizes eating during a specified time period. OBJECTIVES: The aim of this study is to assess the feasibility of a TLE approach in adolescents with obesity using a continuous glucose monitor (CGM) to promote adherence to the intervention. METHODS: We propose a prospective, randomized controlled trial, in 60 adolescents (ages 14–18) with obesity (BMI% ≥ 95th percentile). Youth will be randomized to one of three treatment groups for a 12-week intervention: Group 1) Low sugar and carbohydrate education (LSC, 5% of total daily calories from sugar (< 35 g)/day; < 90 g carbohydrate (CHO)/day) + blinded CGM (used to monitor adherence and glycemic outcomes without real time feedback), Group 2) LSC + TLE (16-h fast/8-h feed for 5 days per week) + blinded CGM, and Group 3) LSC + TLE+ real time feedback via CGM (to evaluate effect of providing CGM data on intervention efficacy). Outcomes will include change in total body fat (TBF) percentage measured on DEXA scan, BMI status and fasting blood glucose at 12 weeks compared to baseline. CONCLUSIONS: TLE is a potentially powerful lifestyle intervention that could be readily integrated into pediatric weight management programs to optimize their impact and accelerate healthy changes. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03954223 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|